Get started
Author

Martina Rahmeh

Activity of the Dual Kinase Inhibitor Lapatinib (GW572016) against HER-2-Overexpressing and Trastuzumab-Treated Breast Cancer Cells
2006 · Gottfried E. Konecny, Mark D. Pegram, et al. · Cancer Research · 914
Nelfinavir and bortezomib inhibit mTOR activity via ATF4‐mediated sestrin‐2 regulation
2013 · Ansgar Brüning, Martina Rahmeh, et al. · Molecular Oncology · 135
PDF
Activity of lapatinib a novel HER2 and EGFR dual kinase inhibitor in human endometrial cancer cells
2008 · G E Konecny, N Venkatesan, et al. · British Journal of Cancer · 112
PDF
Nelfinavir induces the unfolded protein response in ovarian cancer cells, resulting in ER vacuolization, cell cycle retardation and apoptosis
2009 · Ansgar Brüning, Petra Burger, et al. · Cancer Biology & Therapy · 63
PDF
Role of Peroxisome Proliferator-Activated Receptors (PPARs) in Trophoblast Functions
2021 · Lin Peng, Huixia Yang, et al. · International Journal of Molecular Sciences · 42
PDF
Bortezomib treatment of ovarian cancer cells mediates endoplasmic reticulum stress, cell cycle arrest, and apoptosis
2008 · Ansgar Brüning, Petra Burger, et al. · Investigational New Drugs · 42
Factors Influencing the In Vitro Maturation (IVM) of Human Oocyte
2021 · Huixia Yang, Thomas Kolben, et al. · Biomedicines · 39
PDF
Inhibin beta E is upregulated by drug-induced endoplasmic reticulum stress as a transcriptional target gene of ATF4
2012 · Ansgar Brüning, Christina Matsingou, et al. · Toxicology and Applied Pharmacology · 24
The mitochondria-independent cytotoxic effect of nelfinavir on leukemia cells can be enhanced by sorafenib-mediated mcl-1 downregulation and mitochondrial membrane destabilization
2010 · Ansgar Brüning, Martina Rahmeh, et al. · Molecular Cancer · 24
PDF
Prostaglandin E2 receptor 3 signaling is induced in placentas with unexplained recurrent pregnancy losses
2018 · Yao Ye, Aurelia Vattai, et al. · Endocrine Connections · 18
PDF
Prostaglandin receptor EP3 regulates cell proliferation and migration with impact on survival of endometrial cancer patients
2017 · Junyan Zhu, Fabian Trillsch, et al. · Oncotarget · 17
PDF
Nelfinavir induces TRAIL receptor upregulation in ovarian cancer cells
2008 · Ansgar Brüning, Marianne Vogel, et al. · Biochemical and Biophysical Research Communications · 17
Comparison of Histone H3K4me3 between IVF and ICSI Technologies and between Boy and Girl Offspring
2021 · Huixia Yang, Zhi Ma, et al. · International Journal of Molecular Sciences · 15
PDF
EP3 receptor antagonist L798,106 reduces proliferation and migration of SK-BR-3 breast cancer cells
2019 · Anna Hester, Barbara Salzmann, et al. · OncoTargets and Therapy · 15
PDF
Prostaglandin E2 Receptor 4 (EP4) Affects Trophoblast Functions via Activating the cAMP-PKA-pCREB Signaling Pathway at the Maternal-Fetal Interface in Unexplained Recurrent Miscarriage
2021 · Lin Peng, Anca Chelariu-Raicu, et al. · International Journal of Molecular Sciences · 13
PDF
Expression of trophoblast derived prostaglandin E2 receptor 2 (EP2) is reduced in patients with recurrent miscarriage and EP2 regulates cell proliferation and expression of inflammatory cytokines
2020 · Lin Peng, Yao Ye, et al. · Journal of Reproductive Immunology · 11
CTLA‐4 lacking the cytoplasmic domain costimulates IL‐2 production in T‐cell hybridomas
2006 · Axel J Hueber, Franziska G Matzkies, et al. · Immunology and Cell Biology · 10
First Evidence for a Role of Siglec-8 in Breast Cancer
2021 · Anna Trebo, Nina Ditsch, et al. · International Journal of Molecular Sciences · 9
PDF
Promotor analysis of ESR1 in endometrial cancer cell lines, endometrial and endometriotic tissue
2017 · Vanessa Toderow, Martina Rahmeh, et al. · Archives of Gynecology and Obstetrics · 8
KLF11 is an independent negative prognostic factor for breast cancer from a cohort study and induces proliferation and inhibits apoptosis in vitro
2023 · Lili Lin, Kristina Pfender, et al. · Breast Cancer · 6
PDF
Inhibition of Wnt signaling as therapeutic option in platinum-resistant ovarian cancer.
2017 · Fabian Trillsch, Valentina Preinfalk, et al. · Journal of Clinical Oncology · 4
FAM111A Is a Novel Molecular Marker for Oocyte Aging
2022 · Huixia Yang, Thomas Kolben, et al. · Biomedicines · 3
PDF
Correction to: Promotor analysis of ESR1 in endometrial cancer cell lines, endometrial and endometriotic tissue
2018 · Vanessa Todorow, Martina Rahmeh, et al. · Archives of Gynecology and Obstetrics · 1
PDF
RIG-I-Überexpression ohne erhöhte Interferon-ß-Antwort im Endometriumkarzinom: ein Immun-Escape-Mechanismus?
2024 · S. Mitter, L. Müller, et al. · Geburtshilfe und Frauenheilkunde
RIG-I-Überexpression ohne erhöhte Interferon-ß-Antwort im Endometriumkarzinom: ein Immun-Escape-Mechanismus?
2024 · S. A. Mitter, L. Müller, et al. · Geburtshilfe und Frauenheilkunde
Works count: 35
Citation count: 1,542
H-index: 14
I10-index: 17
Year
Topic
Type